Compare · ACAX vs MCK
ACAX vs MCK
Side-by-side comparison of Alset Capital Acquisition Corp. (ACAX) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACAX and MCK operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK carries a market cap of $39.42B.
- MCK has hit the wire 4 times in the past 4 weeks while ACAX has been quiet.
- MCK has more recent analyst coverage (25 ratings vs 0 for ACAX).
- Company
- Alset Capital Acquisition Corp.
- McKesson Corporation
- Price
- $3.85-63.71%
- $828.02-0.90%
- Market cap
- -
- $39.42B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
Alset Capital Acquisition Corp.
Alset Capital Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, as well as businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in Bethesda, Maryland.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest ACAX
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form 8-K filed by Alset Capital Acquisition Corp.
- SEC Form SC 13D/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
Latest MCK
- McKesson Corporation Declares Quarterly Dividend
- McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions
- SEC Form 3 filed by new insider Fraga Francisco
- McKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by McKesson Corporation
- McKesson Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences
- McKesson Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- McKesson Announces Planned CFO Transition
- EVP and Chief Legal Officer Lau Michele sold $2,697,750 worth of shares (2,725 units at $990.00), decreasing direct ownership by 46% to 3,247 units (SEC Form 4)